Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
about
Sugarbaker procedure for pseudomyxoma peritoneiTreatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectivesChemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapyVersatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer.Phosphorylation and hsp90 binding mediate heat shock stabilization of p53Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental studyMalignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysisHyperthermic intraperitoneal chemotherapy in ovarian cancer: rationale and clinical data.Evaluation of ototoxicity in patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin and sodium thiosulfate.Intraperitoneal therapy for peritoneal cancer.Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer.Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement.Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis.A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patientsExtent of Serosal Changes Predicts Peritoneal Recurrence and Poor Prognosis After Curative Surgery for Gastric CancerCatheterization-associated complications of intraperitoneal chemotherapy in advanced gastric cancer.Hemicolectomy with concomitant heated intraperitoneal chemotherapy: a case study.Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy.Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy.Plasmonic photothermal heating of intraperitoneal tumors through the use of an implanted near-infrared source.Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocolMetastases of colorectal cancer to the liver and peritoneum: comparison of surgical paradigms.Targeted hyperthermia using metal nanoparticles.Current devices for high-performance whole-body hyperthermia therapy.Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with Pseudomyxoma peritonei.Surgical management of colorectal peritoneal metastases: treatment and outcomes compared with hepatic metastases.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.Nanocrystals for the parenteral delivery of poorly water-soluble drugsDoes early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?Proposed radiological criteria for pre-operative determination of resectability in peritoneal-based malignancies.A review of 111 anaesthetic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre.Diagnosis of Pseudomyxoma peritonei via endoscopic ultrasound guided fine needle aspiration: a case report and review of literature.Regional immunotherapy for liver and peritoneal metastases.Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumours.Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of recurrent/relapsed ovarian granulosa cell tumor: a single-center experience.New experimental model for single liver lobe hyperthermia in small animals using non-directional microwavesPseudomyxoma peritonei: a need to establish evidence-based standard of care--is this the right trial?
P2860
Q24245207-F266A270-A634-48DB-865D-B2ED79835BE6Q26744031-CBBFC3E0-1DD4-4091-9691-2F57E30C188BQ26768402-4F4FE812-8C37-4832-8BBF-FB8FE67BF63BQ27687617-EB99537F-404C-4266-984E-2FC76F5C82BDQ28214608-D3D13E01-02C5-44C9-8826-3802BBA02ED1Q33681531-C7093DDA-2487-434A-8268-E944E53C7A6DQ33909330-05B20E13-5A54-4B7F-AA07-2B2910E9738DQ34356395-49B35A00-ADC5-41B9-A28F-392D9FD87BF0Q34401647-B8FD2DEC-7880-43CC-A698-F399771188C2Q34789701-1C412A09-C5FC-4CBD-AEC2-06870691E365Q35476298-6AA6C13F-3DFB-42E1-839A-BC2D57479E82Q35757869-52A1B1D0-A3C8-4FC7-84B7-92AD464BB2BFQ35761049-EE6F5CD5-B8A7-4F67-BE47-9E9D769B13AEQ35868066-C3D486E7-929B-49A4-BDF6-27518902A0F8Q36125424-167630EA-0B78-493E-A7D9-5B06E7A8EAFDQ36206977-048D805A-457B-474A-9DD2-CF908B3EE1D4Q36213882-279834F2-CAD4-4DCE-ACE7-D35C00A8E17DQ36375983-761C66D5-6D52-45D6-94EC-5EC4525FA611Q36444374-FD877DAE-AF78-49F9-AC49-A016286F4DD6Q36454362-5D7B182A-925F-4083-805A-9FE53A107420Q37210768-91BD8155-78CD-4B56-BF24-173E3BF0E565Q37308110-6244A690-F48C-4435-A0DF-1E3EC5B8445AQ37316995-2B2527B2-858F-468D-8823-8931647C21B8Q37631871-9CA1DCEF-7707-402C-8FF1-34815BFEE078Q37737340-3689A1BF-6CA8-4433-AB4D-287B16EE06A1Q37991247-F954200D-C754-48B1-B53B-66A20A6C4C86Q38058707-E0DD466B-9278-46E8-B898-ED685AC8C625Q38090517-1BAF19E6-7C5D-41E0-8FCC-07B187257527Q38104343-9DD14CFA-F274-48D5-AA59-C7AE33BEABEBQ38728196-2A1AFD25-87C8-453F-A9E7-6C436A4B851AQ38813355-BBE325AB-D819-4E2F-BFE9-B47BA25662D3Q38819415-C88FA59C-47B8-4FDD-A0C7-5D65C6D9C0F5Q39010898-8FDCEE43-F367-4AF3-8507-97938B570AAEQ39117243-AF3878DD-C0F9-425E-82EF-08209934A549Q39329364-9280046C-44EA-480C-A887-0C79F66DAB39Q40593312-3F10E5CF-A0ED-4669-B01F-17C7BCB0BAA7Q41099259-07BE688D-4C71-4453-A2DC-748F88867D77Q41757594-577B4DD4-48C7-440E-814B-D7880E104254Q42362097-A638A069-B400-4C1B-A90D-9F93F6FDE972Q42562631-F1216713-8F37-493D-8A25-0BB75DB61284
P2860
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
@ast
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
@en
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
@nl
type
label
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
@ast
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
@en
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
@nl
prefLabel
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
@ast
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
@en
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
@nl
P2093
P356
P1476
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
@en
P2093
Van Goethem R
Witkamp AJ
Zoetmulder FA
P304
P356
10.1053/CTRV.2001.0232
P577
2001-12-01T00:00:00Z